Previous Article | Next Article ![]()
Infection and Immunity, January 1999, p. 253-258, Vol. 67, No. 1
Immunology Research, Veterans Affairs Medical
Center, and Earle A. Chiles Research Institute, Portland,
Oregon1;
Department of Microbiology and
Immunology at University of Pennsylvania Medical School, Philadelphia,
Pennsylvania2; and
Department of
Microbiology and Immunology at UCLA, Los Angeles,
California3
Received 28 July 1998/Returned for modification 6 October
1998/Accepted 28 October 1998
Infection of BALB/c mice with Listeria monocytogenes
stimulates an antilisterial immune response evident by the appearance of H2-Kd-restricted CD8+ cytotoxic T
lymphocytes (CTLs) specific for the nanomer peptides amino acids (aa)
91 to 99 of listeriolysin O (LLO 91-99) and aa 217 to 225 of the p60
molecule (p60 217-225). We have introduced point mutations at anchor
residues within LLO 91-99 (92F) or p60 217-225 (218F), and BALB/c
mice infected with L. monocytogenes strains containing
these point mutations do not develop CTLs specific for LLO 91-99 or
p60 217-225, respectively. We have used these strains to test whether
primary CTL responses against L. monocytogenes-derived determinants can be stimulated within an environment of existing antilisterial immunity. We found that the development of a primary L. monocytogenes-specific CTL response is not altered by
existing immunity to L. monocytogenes. For example, primary
immunization with the p60 218F strain of L. monocytogenes
followed by a secondary immunization with wild-type L. monocytogenes results in stimulation of p60 217-225-specific
CTLs at primary response levels and LLO 91-99-specific effectors at
levels consistent with a memory CTL response. Similarly, primary
immunization with the 92F strain of L. monocytogenes
followed by a secondary immunization with wild-type L. monocytogenes results in stimulation of LLO 91-99-specific CTLs
at primary response levels and p60 217-225-specific effectors at
levels consistent with a memory CTL response. These results provide
additional support for the use of L. monocytogenes as a
recombinant vaccine vector and show that antivector immunity does not
inhibit the development of a primary CTL response when the epitope is
delivered by L. monocytogenes as the vaccine strain.
0019-9567/99/$04.00+0
Copyright © 1999, American Society for Microbiology. All rights reserved.
Existing Antilisterial Immunity Does Not Inhibit
the Development of a Listeria monocytogenes-Specific
Primary Cytotoxic T-Lymphocyte Response
*
Corresponding author. Mailing address: Immunology
Research RD21, VAMC, Portland, OR 97201. Phone: (503) 721-7840. Fax:
(503) 273-5135. E-mail: bouwera{at}ohsu.edu.
This article has been cited by other articles:
Copyright © 2009 by the American Society for Microbiology. For an alternate route to Journals.ASM.org, visit: http://intl-journals.asm.org | More Info»